Zhaoke Ophthalmology Announces 2023 Interim Results

Zhaoke Ophthalmology Announces the Completion of NVK002 Phase III Mini-CHAMP Last Patient Last Visit in China

Zhaoke Ophthalmology Establishes Strategic Partnership with Eyebright Medical

Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer™ for the Treatment of Dry Eye Disease

Zhaoke Ophthalmology’s Partner Vyluma Announces FDA Acceptance of New Drug Application for NVK002, its Novel Investigational Treatment for Pediatric Myopia